CRDL
Cardiol Therapeutics
CRDL
CRDL
37 hedge funds and large institutions have $7.43M invested in Cardiol Therapeutics in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $9.59M → $7.43M (-$2.16M)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
37
Holding in Top 10
–
Calls
$155K
Puts
$2K
Top Buyers
| 1 | +$255K | |
| 2 | +$92.8K | |
| 3 | +$77.2K | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$53.4K |
| 5 |
LSA
Lion Street Advisors
Austin,
Texas
|
+$24.8K |
Top Sellers
| 1 | -$141K | |
| 2 | -$48.8K | |
| 3 | -$48.4K | |
| 4 |
VF
Virtu Financial
New York
|
-$31.9K |
| 5 |
LPL Financial
San Diego,
California
|
-$23.4K |
